Health & Life Sciences leaders are bullish on AI, anticipating transformational change in both patient-facing and operational capacities. This study is based on survey results from leaders across Providers, Payers, Medtech and Life Sciences and outlines current and planned AI investments, top use cases, adoption challenges and defined AI value drivers. This is a commissioned study conducted by Forrester Consulting on behalf of Salesforce…
Date:
More like thisRelated
RISK MANAGEMENT FROM RISK CONTROL TO GROWTH ENGINE
As organisations navigate an increasingly complex landscape shaped by...
60% of AU and SG brands missed their moment last year.
Klaviyo surveyed 400+ B2C marketers across Australia and Singapore...
AI hasn’t created “the AI shopper.” It’s created four.
Most brands are making a costly assumption: that their...
What is discounting actually costing ANZ brands?
ew research from marketing effectiveness expert James Hurman across...